Clinical trial
iHIVARNA Clinical Trial in HIV Infected Individuals
NCT02888756 · Rob Gruters, Other · Terminated
Key facts
| NCT number | NCT02888756 |
|---|---|
| Title | iHIVARNA Clinical Trial in HIV Infected Individuals |
| Official title | A Phase IIa Randomized, Placebo Controlled, Double Blinded Study to Evaluate the Safety and Immunogenicity of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy |
| Acronym | iHIVARNA-01 |
| Lead sponsor | Rob Gruters, Other |
| Collaborators | Institut d'Investigacions Biomèdiques August Pi i Sunyer IrsiCaixa Institute of Tropical Medicine, Belgium Vrije Universiteit Brussel Synapse bv Industry Asphalion eTheRNA immunotherapies CR2O… |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | iHIVARNA-01, TriMix, Placebo |
| Enrollment | 33 |
| Start date | Apr 4, 2017 |
| Primary completion | Feb 12, 2018 |
| Completion | Feb 12, 2018 |
| First posted | Sep 5, 2016 |
| Last update posted | Dec 23, 2019 |
| Countries | Belgium, Netherlands, Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: